Clinical trial registry record

Geriatric Assessment Screening Tool for the Identification of At-Risk Older Adults Who Are Undergoing Cancer Treatment

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated April 29, 2025.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT04788758
Last registry update
April 29, 2025
Status
Completed
Phase
Phase not reported
Sponsor
Thomas Jefferson University
Enrollment
76
Countries
United States
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
NA · SINGLE GROUP · HEALTH SERVICES RESEARCH · NONE
Evidence population
Human clinical study registration
Participants
76
Population
ALL
Duration
2020-01-29 to 2022-05-25
Intervention
Educational Intervention; Screening Questionnaire Administration; Referral; Questionnaire Administration
Comparator
Not reported
Outcomes measured
Overall assessment score: Pre — Before self-administered learning module; Overall assessment score: Post — After self-administered learning module; Number of patients screened — Up to 30 months; Number of patients who refused — Up to 30 months; Time it took to screen — Up to 30 months; Number of referrals to Senior Adult Oncology Center (SAOC) — Up to 30 months; Number of completed SAOC visits — Up to 30 months; Positive predictive value of the G8 — Up to 30 months
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Cancer and ageing · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Title supplies ageing or longevity context.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

cancer and aging
Read the original source →Export JSON